Skip to textbook content
Doctor’s PassportTextbook
TopicsAll topics

Loading topic navigation…

Textbook navigation
TopicsAll topics

Loading topic navigation…

Educational draft · awaiting clinical reviewUse Rapid for revision, not patient-care decisions. Check current national and local guidance and the BNF or BNFC before acting.

Acute nephritic syndrome and post-streptococcal disease

Paediatrics and child health · UK scope · Sources checked 27 Aug 2026 · Clinical review pending

RapidFull
!
Hypertensive, hyperkalaemic or oliguric emergency

Pulmonary oedema, encephalopathy, seizure, severe hypertension, rapidly rising creatinine, hyperkalaemia, severe acidosis, oliguria or anuria can complicate acute glomerulonephritis and may require kidney replacement therapy.

Action: Admit, obtain senior paediatric and nephrology help immediately, use continuous physiological monitoring, establish accurate weight and fluid balance, check ECG, renal profile and blood gas, and treat life-threatening potassium, blood-pressure, respiratory and fluid complications through paediatric emergency protocols. Do not give unmeasured fluid boluses to an overloaded child.

Synopsis

Recognise the haematuria-hypertension-oedema syndrome, stabilise fluid overload and kidney injury, confirm a post-infectious pattern without premature closure, and identify features requiring urgent nephrology or biopsy.

  • Acute nephritic syndrome is glomerular haematuria with variable proteinuria, hypertension, oedema, oliguria and reduced kidney function; red-cell casts strongly support glomerular bleeding.
  • Post-streptococcal glomerulonephritis typically follows streptococcal pharyngitis by about 1–2 weeks or skin infection by about 3–6 weeks.
  • The urine may look smoky, tea or cola coloured. Periorbital oedema is common, but the dangerous physiology is intravascular salt and water expansion with hypertension.
  • First-line assessment includes blood pressure against age, sex and height centiles, neurological and respiratory examination, weight, urine output and complete fluid balance.
  • First-line investigations are urinalysis and microscopy, urine protein:creatinine ratio and culture, serum creatinine and electrolytes, albumin, FBC and complement C3/C4.
  • Evidence of antecedent streptococcal infection comes from ASO and anti-DNase B titres interpreted with the clinical interval; throat or skin cultures may already be negative.
  • The typical complement pattern is low C3 with normal C4. Repeat C3 at 6–8 weeks; failure to normalise prompts evaluation for C3 glomerulopathy, lupus or another diagnosis.
  • First-line management is supportive: salt restriction, fluid input approximately matching urine plus insensible losses, daily weight and frequent blood-pressure and renal monitoring.
  • Furosemide is used for clinically important fluid overload and often improves volume-mediated hypertension; persistent hypertension may need a calcium-channel blocker under specialist direction.
  • A 10-day penicillin course eradicates a remaining nephritogenic group A streptococcus and limits transmission, but it does not reverse immune-complex nephritis already established.
  • Dialysis decisions are clinical and include refractory hyperkalaemia, acidosis, pulmonary oedema, uraemic complications or fluid overload, not a creatinine number alone.
  • Most post-streptococcal symptoms resolve over 2–3 weeks, while microscopic haematuria can persist for 1–2 years; follow blood pressure, proteinuria, function and complement trajectory.

Key red flags

Headache, vomiting, visual change, confusion or seizure with hypertension suggests hypertensive encephalopathy and requires emergency treatment.

Breathlessness, hypoxaemia, basal crepitations, gallop rhythm or rapidly increasing weight suggests pulmonary oedema from salt and water retention.

Rapidly rising creatinine, potassium elevation, severe acidosis, oliguria or anuria requires immediate nephrology discussion and dialysis assessment.

Nephrotic-range proteinuria, marked hypoalbuminaemia, rapidly progressive function loss or systemic vasculitis features suggests a severe glomerular process beyond uncomplicated post-infectious disease.

Persistently low C3 after 6–8 weeks, low C3 and C4 together, positive ANA or ANCA, or recurrent episodes argues against a simple resolving post-streptococcal course.

A family history of kidney failure or deafness, hearing abnormalities or ocular features raises concern for inherited collagen disease.

Investigation priorities

01
First-line: urinalysis, microscopy and protein:creatinine ratioFirst stepFirst line

Confirm glomerular blood, quantify protein and exclude urinary infection.

Management branches

InitialStabilise and phenotype nephritis

A child has haematuria with oedema, hypertension or reduced urine.

  1. Measure paediatric-centile blood pressure, weight, respiratory and neurological status and establish strict fluid balance.
  2. Obtain urine sediment and protein quantification, renal profile, FBC, albumin, complement and streptococcal evidence.
  3. Admit when hypertension, oedema, AKI, oliguria, electrolyte disturbance or diagnostic uncertainty requires monitored treatment.

Key medicines

FurosemideFor nephritic fluid overload under paediatric supervision, start 0.5 mg/kg orally or intravenously once daily; titrate according to response up to 1 mg/kg per dose twice daily as described in the NHSGGC renal guideline.Confirm true overload, urine output and perfusion before dosing. Monitor weight, blood pressure, sodium, potassium, creatinine and ototoxicity risk; do not escalate ineffective diuresis instead of arranging dialysis assessment.
PhenoxymethylpenicillinFor residual group A streptococcal eradication, give orally for 10 days: age 1 to 5 years 125 mg four times daily, age 6 to 11 years 250 mg four times daily, and age 12 to 17 years 500 mg four times daily, checking current BNFC guidance.Check immediate penicillin allergy, age, formulation and swallowing. Use a current alternative regimen if genuinely allergic and complete the course; do not represent antibiotic therapy as renal immunomodulation.
Open full textbook →Answer 2 questions
Sources and review status3 sources · checked 27 Aug 2026 · clinical review pending+
Sources

Sources and review status

National guidance is shown before implementation-dependent detail. Typical adult dose examples remain subject to patient factors, contraindications and the live BNF or specialist protocol. Source check completed 27 Aug 2026; clinical approval remains outstanding.

  • NHSGGC paediatric glomerulonephritis guidelineAcute nephritis investigations, fluid and pressure management, referral and post-streptococcal trajectory.
  • NICE NG148 acute kidney injuryAKI recognition, ultrasound, referral and kidney replacement indications.
  • InfoKID glomerulonephritisUK child and family explanation of glomerular inflammation, tests, treatment and follow-up.

Editorial contact: Doctor’s Passport editorial team. Source-check date is separate from clinical approval. Report a content problem · Content changes

Authoring stateRapid draftClinical stateAwaiting reviewJurisdictionUnited Kingdom